drugset

drugset / Trial / NCT00444860

ZOSTAVAX(R) Local Registration Trial (V211-019)

NCT00444860 ↗

Phase 3 Completed 150 enrolled Merck Sharp & Dohme LLC

Non-randomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to obtain safety and immunogenicity data for the refrigerator-stable formulation of ZOSTAVAX(R) in taiwanese adults.

Timeline

Start: 2007-03
Primary completion: 2007-05
Completion: 2007-05

Publications

Results Yao CA, Chen LK, Huang KC. The immunogenicity and safety of zoster vaccine in Taiwanese adults. Vaccine. 2015 Mar 24;33(13):1515-7. doi: 10.1016/j.vaccine.2015.01.085. Epub 2015 Feb 11.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Varivax	Vaccine	0.65 ml	—

Indications